Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pfizer Raises 2026 Forecast, Extending Big Pharma Windfall
Pfizer Inc. raised its full-year outlook after it outperformed in the third quarter, as growing demand for its newer medicines helped the drugmaker offset declining sales of its Covid products. The drugmaker now expects full-year revenue of $62…
Bayer Raises Earnings Outlook on Pharma Recovery
raised its full-year earnings guidance, citing a recovery in its pharmaceutical arm after strong demand for key drugs allowed the group to offset market pressures at its agricultural and consumer-health divisions. The German group said Tuesday that…
Yogi Government Plans 200-Acre Bio-Pharma Park in Pilibhit to Boost UP's Pharmaceutical Industry | Dynamite News
Post Published By: Pradeep Tripathi Updated: 3 November 2026, 7:39 PM IST Lucknow: The Yogi government is stepping up efforts to establish Uttar Pradesh as a major hub for pharmaceutical and biotechnology manufacturing. As part of this initiative…
HRV Pharma to acquire German firm Phatebo
HRV Pharma, a virtual pharmaceutical company headquartered in Hyderabad, is acquiring Phatebo GmbH, a licensed pharmaceutical wholesaler in Germany specialising in clinical trial supply. The acquisition will take it beyond active pharmaceutical…
Spektus Pharma and GEBRO Holding Announce Global Commercialization Partnership for ActraFlex
Novel twice-daily extended-release tramadol/paracetamol formulation combines Spektus' proprietary AmyloFlex technology with GEBRO's established Diliban brand. LAVAL, QC and FIEBERBRUNN, Austria, Nov. 3, 2026 /CNW/ -- Spektus Pharma Inc. ('Spektus')…
Western Pharma Giants Paid Millions to Russian Distributors Linked to Fraud, Whistleblower Report Says
Four major Western pharmaceutical companies paid tens of millions of dollars in unusually high bonuses to Russian middlemen to supply cancer drugs to state hospitals, according to whistleblower documents submitted to U.S. financial regulators. The…
Spyglass Pharma (NASDAQ:SGP) Hits New 1-Year High - What's Next?
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) shares reached a new 52-week high on Tuesday. The stock traded as high as $34.24 and last traded at $34.6730, with a volume of 1,557 shares traded. The stock had previously closed at $33.64. SGP…
Gotthard Pass road to close for winter on Thursday
The walking and cycling path through the Schöllenen has been closed since Monday, the Federal Roads Office (ASTRA) announced on Tuesday. ASTRA had agreed on the closure with the Uri Cantonal Office for the Operation of National Roads (AfBN).
Switzerland celebrates fifth three-star Michelin restaurant
‘Maximum discretion' is a thing of the past: Swiss politicians step onto the world stage Read more: ‘Maximum discretion' is a thing of the past: Swiss politicians step onto the world stage Alain Werner: a life spent fighting impunity…
Switzerland faces pressure from US drug pricing policy
Swiss drug prices are already among the highest in the world, but prices in the US are significantly steeper. The US government wants to change that and is pressuring pharmaceutical companies to offer new medicines at lower prices in the American…
20,696 Royalty Pharma PLC $RPRX Shares Purchased by Profund Advisors LLC
Profund Advisors LLC boosted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 445.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,344…
SWISS profits rise despite high fuel costs
The airline explained that the high demand for air travel and the encouraging performance of the cargo business had more or less offset the additional fuel costs. Turnover rose by 5.3% to CHF4.38 billion. However, SWISS was barely able to improve…
Royalty Pharma PLC $RPRX Stock: Park Avenue Securities LLC Cuts Holdings
Park Avenue Securities LLC lessened its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 52.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 22,492 shares of the…
Moberg Pharma granted new US patent
My understanding is that this doesn't apply to 48 weeks once daily. It does cover the therapeutically relevant periods for the population tested against during the interim analysis in the 2019 data. That big spike in mycological cure around 24…
Centerra Gold: Thompson Creek Could Deliver More Upside After A 71% Rally (NYSE:CGAU)
Centerra (CGAU) is rated a cautious Buy, with 20–24% upside as Thompson Creek's production and higher molybdenum prices drive future earnings. Thompson Creek's heavy capex is largely complete; peak spending is behind, and production is set…
Receive a Daily briefing on Pharma Industry News
Get Started